Antibiotics can be lifesaving medicines that fight bacterial infection, but the antibiotic Tequin can cause changes in blood sugar levels that can be life-threatening to older patients in particular, ...

On April 27, 2006, Dow Jones reported that Bristol-Myers Squibb had decided to stop selling Tequin, an antibiotic found to increase the risk of blood-sugar problems. BMS made a "recent decision to ...

Bristol-Myers Squibb said Monday it plans to stop making its antibiotic Tequin following questions about its effects on blood sugar levels in some patients. A Bristol-Myers Squibb spokesperson told ...

Tequin is the drug used to treat pneumonia, bronchitis and other infections. Bristol-Myers Squibb Co. (BMY) is manufacturing the drug. The U.S. Food and Drug Administration said that the drug would ...

Dec. 15, 2004 — The U.S. Food and Drug Administration (FDA) approved in September revisions to safety labeling to advise healthcare professionals of the following changes: use of fluoxetine ...

WHAT: Tequin (gatifloxacin), a broad-spectrum prescription antibiotic from Bristol-Myers Squibb Co. NEW USE: Now available in a short course – five days instead of seven – to knock out germs that make ...

An antibiotic suspected of causing dangerous changes in blood-sugar levels has been pulled from the market. Production of the drug gatifloxacin (sold under the brand name Tequin) has been discontinued ...

Bristol-Myers Squibb is to slap a stronger warning on its antibiotic Tequin after continued reports of both hypoglycaemia (low blood sugar) and hyperglycemia (high blood sugar) in patients given the ...

Bethesda, MD - Bristol-Myers Squibb (BMS) has notified the US Food and Drug Administration (FDA) about proposed changes to the label for the antibiotic gatifloxacin (Tequin), revising it to include a ...

I am desperately seeking help. My husband had pneumonia and received Tequin 400mg for 14 days. During the second week he started complaning about cramps in his right leg, at first we thought it was ...

An antibiotic suspected of causing dangerous changes in blood-sugar levels has been pulled from the market. Production of the drug gatifloxacin (sold under the brand name Tequin) has been discontinued ...